Referentielijst

Aalten P (2005)
Aalten P, Vugt de ME, Jaspers N et al. The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. International Journal of Geriatric Psychiatry 2005; 523-530.

Achterberg WP (2007)
Achterberg WP, Pot AM, Scherder EJ et al. Pain in the nursing home: assessment and treatment on different types of care wards. Journal of Pain and Symptom Management 2007; 34: 480-487.

Alexopoulos GS (1988)
Alexopoulos GS, Abrams RC, Young RC et al. Cornell Scale for Depression in Dementia. Biological Psychiatry 1988; 23: 271-284.

Aminoff BZ (2004)
Aminoff BZ, Purits E, Noy S et al. Measuring the suffering of end-stage dementia: reliability and validity of the Mini-Suffering State Examination. Archives of Gerontology and Geriatrics 2004; 38: 123-130.

Aminoff BZ (2006)
Aminoff BZ, Adunsky A. Their last 6 months: suffering and survival of end-stage dementia patients. Age and Ageing 2006; 35: 597-601.

Arnts W (1989)
Arnts W, Oostwaard van P, Rooyakkers A. Physiotherapy treatment for paratonia. Nederlands Tijdschrift voor Fysiotherapie 1989; 99, 216-220.

Ayalon L (2006)
Ayalon L, Gum AM, Feliciano L et al. Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Archives of Internal Medicine 2006; 166: 2182-2188.

Bains J (2002)
Bains J, Birks JS, Dening TR. The efficacy of antidepressants in the treatment of depression in dementia. Cochrane Database of Systematic Reviews 2002, 4: CD003944.

Ballard C (2006)
Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, 1: CD003476.

Ballard C (2009)
Ballard C, Hanney ML, Theodoulou M et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurology 2009; 8: 151-157.

Ballard CG (2009)
Ballard CG, Gauthier S, Cummings JL et al. Management of agitation and aggression associated with Alzheimer disease. Nature Reviews. Neurology 2009; 5: 245-255.

Been de M (2008)
Been de M, Dijk van KR, Erbrink JF et al. Beginselen en vuistregels bij wilsonbekwaamheid bij oudere cliënten met een complexe zorgvraag. Utrecht: NVVA, 2008.

Birks J (2006)
Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006; 1: CD005593.

Birks J (2006)
Birks J, Flicker L. Donepezil for mild cognitive impairment. Cochrane Database of Systematic Reviews 2006; 3: CD006104.

Birks J (2006)
Birks J, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database of Systematic Reviews 2006; 1: CD001190.

Birks J (2009)
Birks J, Grimley Evans J, Iakovidou V et al. Rivastigmine for Alzheimer's disease. Cochrane Database of Systematic Reviews 2009; 2: CD001191.

Boer de ME (2007)
Boer de ME, Hertogh CM, Dröes RM et al. Suffering from dementia - the patient's perspective: a review of the literature. International Psychogeriatrics 2007; 19: 1021-1039.

Brandt HE (2006)
Brandt HE, Ooms ME, Ribbe MW et al. Predicted survival vs. actual survival in terminally ill noncancer patients in Dutch nursing homes. Journal of Pain and Symptom Management 2006; 32: 560-566.

Broeck van B (2007)
Broeck van B, Broeckhoven van C, Kumar-Singh S. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches. Neuro-degenerative Diseases 2007; 4: 349-365.

CBO (2005)
CBO. Richtlijn Diagnostiek en medicamenteuze behandeling van dementie 2005; Utrecht.

Christensen DB (1998)
Christensen DB, Benfield WR. Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients. Journal of the American Geriatric Society 1998; 46: 620-625.

Craig D (2005)
Craig D, Birks J. Rivastigmine for vascular cognitive impairment. Cochrane Database of Systematic Reviews 2005; 2: CD004744.

Craig D (2006)
Craig D, Birks J. Galantamine for vascular cognitive impairment. Cochrane Database of Systematic Reviews 2006; 1: CD004746.

Eijle van J (1991)
Eijle van J. Werkboek PDL. Middelharnis: Mobicare, 1991.

Emre M (2004)
Emre M, Aarsland D, Albanese A et al. Rivastigmine for dementia associated with Parkinsons's disease. New England Journal of Medicine 2004; 351: 2509-2518.

Ferri CP (2005)
Ferri CP, Prince M, Brayne C et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112-2117.

Gaugler JE (2009)
Gaugler JE, Yu F, Krichbaum K et al. Predictors of nursing home admission for persons with dementia. Medical Care 2009; 47: 191-198.

Gessert CE (2000)
Gessert CE, Forbes S, Bern-Klug M. Planning end-of-life care for patients with dementia: roles of families and health professionals. Omega (Westport) 2000: 42: 273-291.

Gezondheidsraad (2002)
Gezondheidsraad. Dementie: advies van een commissie van de Gezondheidsraad. Gezondheidsraad, 2002.

Gillick M (1999)
Gillick M, Berkman S, Cullen L. A patient-centered approach to advance medical planning in the nursing home. Journal of the American Geriatric Society 1999; 47: 227-230.

Gillick MR (2004)
Gillick MR. Advance care planning. New England Journal of Medicine 2004; 350: 7-8.

Graff MJ (2006)
Graff MJ, Vernooij-Dassen MJ, Thijssen M et al. Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial. BMJ 2006; 333: 1196.

Hickman SE (2009)
Hickman SE, Nelson CA, Moss AH et al. Use of the Physician Orders for Life-Sustaining Treatment (POLST) paradigm program in the hospice setting. Journal of Palliative Medicine 2009; 12: 133-141.

Hobbelen J (2003)
Hobbelen J, Bie de R, Rossum van E. Effect of passive movement on severity of paratonia:a partially blinded, randomized clinical trial. Nederlands Tijdschrift voor Fysiotherapie 2003; 113: 132-137.

Hobbelen JS (2006)
Hobbelen JS, Koopman RT, Verhey FR et al. Paratonia: a Delphi procedure for consensus definition. Journal of Geriatric Physical Therapy 2006; 29: 50-56.

Hobbelen JS (2008)
Hobbelen JS, Koopmans RT, Verhey FR et al. Diagnosing paratonia in the demented elderly: reliability and validity of the Paratonia Assessment Instrument (PAI). International Psychogeriatrics 2008; 20: 840-852.

Horgas AL (2009)
Horgas AL, Elliott AF, Marsiske M. Pain assessment in persons with dementia: relationship between self-report and behavioral observation. Journal of the American Geriatric Society 2009; 57: 126-132.

Hughes CP (1982)
Hughes CP, Berg L, Danziger WL et al. A new clinical scale for the staging of dementia. British Journal of Psychiatry 1982; 140: 566-572.

Kavirajan H (2009)
Kavirajan H. Memantine: a comprehensive review of safety and efficacy. Expert Opinion on Drug Safety 2009; 8: 89-109.

Konovalov S (2008)
Konovalov S, Muralee S, Tampi RR. Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. International Psychogeriatrics 2008; 20: 293-308.

Koopmans RT (2009)
Koopmans RT, Ekkerink JL, Weel van C. Survival to late dementia in Dutch nursing home patients. Journal of the American Geriatric Society 2009; 51: 184-187.

Koopmans RT (2007)
Koopmans RT, Sterren van der KJ, Steen van der JT. The 'natural' endpoint of dementia: death from cachexia or dehydration following palliative care? International Journal of Geriatric Psychiatry 2007; 22: 350-355.
 
Lebert F (2004)
Lebert F, Stekke B, Hasenbroekx C et al. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dementia and Geriatric Cognitive Disorders 2004; 17, 355-359.

Leemrijse C (2005)
Leemrijse C, Boer de M, Ribbe M. Paramedic care in Dutch nursing homes; explaining the differences? Utrecht: NIVEL, 2005.

Lemstra AW (2003)
Lemstra AW, Eikelenboom P, Gool van WA. The cholinergic deficiency syndrome and its therapeutic implications. Gerontology 2003; 49: 55-60.

Livingston G (2005)
Livingston G, Johnston K, Katona C et al. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. American Journal of Psychiatry, 2005; 162: 1996-2021.

Lonergan E (2002)
Lonergan E, Luxenberg J, Colford J. Haloperidol for agitation in dementia. Cochrane Database of Systematic Reviews 2002; 2: CD002852.

Lonergan E (2009)
Lonergan E, Luxenberg J. Valproate preparations for agitation in dementia. Cochrane Database of Systematic Reviews 2009; 3: CD003945.

Loy C (2006)
Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database of Systematic Reviews 2006; 1: CD001747.

Lucca U (1994)
Lucca U, Tettamanti M, Forloni G et al. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biological Psychiatry 1994; 36: 854-856.

Lunney JR (2003)
Lunney JR, Lynn J, Foley DJ et al. Patterns of functional decline at the end of life. JAMA 2003; 289: 2387-2392.

Lyketsos CG (2003)
Lyketsos CG, Delcampo L, Steinberg M et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Archives of General Psychiatryy 2003; 60, 737-746.

Maidment I (2006)
Maidment I, Fox C, Boustani M. Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database of Systematic Reviews 2006; 1: CD004747.

Malouf R (2004)
Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database of Systematic Reviews 2004; 1: CD004395.

McKeith I (2000)
McKeith I, Del Ser T, Spano P et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356, 2031-2036.

McShane R (2006)
McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database of Systematic Reviews 2006; 2: CD003154.

Meehan KM (2002)
Meehan KM, Wang H, David SR et al. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology 2002; 26, 494-504.

Ministerie van VWS (2009)
Ministerie van VWS, Zorgverzekeraars Nederland, Alzheimer Nederland, ActiZ. Leidraad ketenzorg dementie. Den Haag 2009.

Mottram P (2006)
Mottram P, Wilson, K, Strobl J. Antidepressants for depressed elderly. Cochrane Database of Systematic Reviews 2006; 1: CD003491.

NVVA (2008)
NVVA. Richtlijn probleemgedrag. Utrecht, 2008.

Nygaard HA (2005)
Nygaard HA, Jarland M. Are nursing home patients with dementia diagnosis at increased risk for inadequate pain treatment? International Journal of Geriatric Psychiatry 2005; 20: 730-737.

Olde Rikkert MG (1994)
Olde Rikkert MG, Bogaers MA, Bruijns E. Hypodermoclysis, an undervalued rehydration method in geriatrics. Tijdschrift voor Gerontology en Geriatrie 1994; 25: 197-204.

Olin JT (2002)
Olin JT, Schneider LS, Katz IR et al. Provisional diagnostic criteria for depression of Alzheimer disease. American Journal of Geriatric Psychiatry 2002; 10: 125-128.

Pasman HR (2003)
Pasman HR, The BA, Onwuteaka-Philipsen BD et al. Feeding nursing home patients with severe dementia: a qualitative study. Journal of Advanced Nursing 2003;42: 304-11

Pasman HR (2004)
Pasman HR, Onwuteaka-Philipsen BD, Ooms ME et al. Forgoing artificial nutrition and hydration in nursing home patients with dementia: patients, decision making, and participants. Alzheimer Disease and Associated Disorders 2004; 18: 154-162.

Pasman HRW (2006)
Pasman HRW, Onwuteaka-Philipsen BD, Kriegsman DMW. Mate van onwelbevinden bij psychogeriatrische patiënten met vergevorderde dementie, die zelf niet of nauwelijks meer eten of drinken, bij wie in het verpleeghuis is besloten af te zien van kunstmatige toediening van voedsel en vocht. Nederlands Tijdschrift voor Geneeskunde 2006; 150: 243-248.

Perry M (2008)
Perry M, Melis RJ, Teerenstra S et al. An in-home geriatric programme for vulnerable community-dwelling older people improves the detection of dementia in primary care. International Journal of Geriatric Psychiatry 2008; 23: 1312-1319.

Pollock BG (2007)
Pollock BG, Mulsant BH, Rosen J et al. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. American Journal of Geriatric Psychiatry 2007; 15, 942-952.

Rakt van de J (1997)
Rakt van de J. The development of a fetal position in psychogeriatric patients; a hypothesis. Fysiotherapie en ouderenzorg 1997; juni: 2-6.

Reisberg B (1982)
Reisberg B, Ferris SH, Leon de MJ et al. The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry 1982; 139: 1136-1139.

Riemersma-van der Lek RF (2008)
Riemersma-van der Lek RF, Swaab DF, Twisk, J et al. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 2008; 299: 2642-2655.

Salari MA (2004)
Salari MA, Plaisier AJ. Landelijk zorgprogramma jong-dementerenden. Utrecht, 2004.

Sampson EL (2009)
Sampson EL, Candy B, Jones L. Enteral tube feeding for older people with advanced dementia. Cochrane Database of Systematic Reviews 2009; 2: CD007209.

Scherder EJ (2003)
Scherder EJ, Sergeant JA, Swaab DF. Pain processing in dementia and its relation to neuropathology. Lancet Neurology 2003; 2: 677-686.

Scherder EJ (2003)
Scherder EJ, Slaets J, Deijen JB et al. Pain assessment in patients with possible vascular dementia. Psychiatry 2003; 66: 133-145.

Selbaek G (2007)
Selbaek G, Kirkevold O, Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. International Journal of Geriatric Psychiatry 2007; 22, 843-849.

Semla TP (1993)
Semla TP, Cohen D, Paveza G et al. Drug use patterns of persons with Alzheimer's disease and related disorders living in the community. Journal of the American Geriatric Society 1993; 41: 408-413.

Siddique (2009)
Siddique, H, Hynan LS, Weiner MF. Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease. Journal of Clinical Psychiatry 2009; 70; 915-918.

Smits CH (2007)
Smits CH, Lange de J, Dröes RM et al. Effects of combined intervention programmes for people with dementia living at home and their caregivers: a systematic review. International Journal of Geriatric Psychiatry 2007; 22: 1181-1193.

Souren LE (1997)
Souren LE, Franssen EH, Reisberg B. Neuromotor changes in Alzheimer's disease: implications for patient care. Journal of Geriatric Psychiatry and Neurology 1997; 10: 93-98.

Spijker A (2008)
Spijker A, Vernooij-Dassen M, Vasse E et al. Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis. Journal of the American Geriatric Society 2008; 56: 1116-1128

Steen van der JT (2002)
Steen van der JT, Ooms ME, Wal van der G et al. Measuring discomfort in patients with dementia. Validity of a Dutch version of the Discomfort Scale--dementia of Alzheimer type (DS-DAT)]. Tijdschrift voor Gerontology en Geriatrie 2002; 33: 257-263.

Steen van der JT (2003)
Steen van der JT, Adèr HJ, Assendelft van JH et al. Retrospective assessment of the Dutch version of the Discomfort Scale--Dementia of Alzheimer Type (DS-DAT): is estimation sufficiently valid and reliable? Tijdschrift voor Gerontology en Geriatrie 2003; 34: 254-259.

Steen van der JT (2007)
Steen van der JT, Mitchell SL, Frijters DH et al. Prediction of 6-month mortality in nursing home residents with advanced dementia: validity of a risk score. Journal of the American Medical Directors Association 2007; 8: 464-468.

Sultzer DL (1997)
Sultzer DL, Gray KF, Gunay I et al. A double-blind comparison of trazodone and haloperidol for the treatment of agitation in patients with dementia. American Journal of Geriatric Psychiatry 1997; 5: 60-69.

Szirmai I (2002)
Szirmai I, Vastagh I, Szombathelyi E et al. Strategic infarcts of the thalamus in vascular dementia. Journal of the Neurological Sciences 2002; 203: 91-97.

Tanaka M (2002)
Tanaka M, Okamoto K, Hirai S. Cerebral blood flow and oxygen metabolism in vascular dementia evaluated by positron emission tomography: importance of frontal lobe hypoperfusion and hypometabolism. Annals of the New York Academy of Sciences 2002; 977: 135-140.

Teri L (1998)
Teri L, McCurry SM, Buchner DM et al. Exercise and activity level in Alzheimer's disease: a potential treatment focus. Journal of Rehabilitation Research and Development 1998; 35: 411-419.

Vida S (1994)
Vida S, Des Rosiers P, Carrier L et al. Prevalence of depression in Alzheimer's disease and validity of Research Diagnostic Criteria. Journal of Geriatric Psychiatry and Neurology 1994; 7: 238-244.

Volicer L (2002)
Volicer L, Cantor MD, Derse AR et al. Advance care planning by proxy for residents of long-term care facilities who lack decision-making capacity. Journal of the American Geriatric Society 2002; 50: 761-767.

Weert van JC (2005)
Weert van JC, Dulmen van AM, Spreeuwenberg PM et al. Behavioral and mood effects of snoezelen integrated into 24-hour dementia care. Journal of the American Geriatric Society 2005; 53: 24-33.

Wild R (2003)
Wild R, Pettit T, Burns A. Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database of Systematic Reviews 2003; 3: CD003672.

Winblad B (2007)
Winblad B, Jones RW, Wirth Y et al. Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials. Dementia and Geriatric Cognitive Disorders 2007; 24: 20-27.

Xie J (2008)
Xie J, Brayne C, Matthews FE. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ 2008; 336: 258-262.

Zuidema SU (2006)
Zuidema SU, Iersel van MB, Koopmans RT et al. Werkzaamheid en bijwerkingen van antipsychotica voor neuropsychiatrische symptomen bij dementie: een systematische review. Nederlands Tijdschrift voor Geneeskunde 2006; 150: 1565-1573.

Zuidema SU (2007)
Zuidema SU, Derksen E, Verhey FR et al. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. International Journal of Geriatric Psychiatry 2007; 22: 632-638.

Zwakhalen SM (2006)
Zwakhalen SM, Hamers JP, Abu-Saad HH et al. Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools. BMC Geriatrics 2006; 6: 3.

Zwakhalen SM (2006)
Zwakhalen SM, Hamers JP, Berger MP. The psychometric quality and clinical usefulness of three pain assessment tools for elderly people with dementia. Pain 2006; 126: 210-220.